Advancing CMC for Autologous Cell Therapies: Building Robust, Scalable Platforms
18 Sep 2025
Cell Therapy Manufacturing: Automation, Assays & the Allo-Auto Divide
- Streamlining upstream and downstream workflows to support consistent and scalable autologous production
- Implementing sensitive, phase-appropriate assays and comparability studies to ensure product quality and potency
- Regulatory Alignment: Designing CMC frameworks that anticipate regulatory expectations across development stages
